GE Healthcare is bullish on the public sector in India and is aiming to rake in substantial earnings through the public-private partnership (PPP) route. The company has already worked on projects with the Gujarat and Maharashtra governments and is looking to partner with West Bengal, among others.

The healthcare technology major’s domestic arm had a turnover of about $500 million (Rs 2,342 crore) last year and expects to grow between 16 and 20 per cent this year. While exports from India were likely to remain flat this year, its domestic business would grow by 25-30 per cent, of which the public sector sales would contribute up to 25 per cent, GE Healthcare President & CEO (South Asia) V Raja said.

Also Read   Related Stories News Now - GE Healthcare eyes PPP route - GE Healthcare launches low-cost portable ECG - GE Healthcare's new initiatives to expand IT India biz - GE sees healthy gains in low-cost medical devices - 'Healthcare, energy biz will be biggest growth engines' - Wipro GE to consolidate healthcare biz

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

“The PPP route is a win-win situation for everyone. It makes sense, as capital investment for world-class equipment at government facilities can be done by us, while the patient pays the same as before. This way, the government does not have to pay for technology and can provide effective healthcare at a lower cost, while we can capitalise on large volumes,” Raja said here on Friday. He was in the city to inaugurate eastern India’s first molecular imaging PET/CT System. “We have already worked with and supported a number of states. Presentations have been made to the West Bengal government at the highest levels. The government has to play a role and we can partner with them. It is a thrust area for us,” he explained.

GE Healthcare also intends to go on with its research and development (R&D) program in India at its John F Welch Research Centre in Bangalore.

“Our main investment in increasing the size of the R&D team here. We have about 1,100 people already, but we will continue to add between 100 and 150 more personnel every year. On an average, our R&D spend in India is in the range of $40 million annually,” Raja said.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : GE Healthcare | V Raja | PET/CT | John F Welch   Read Business news in  Advertisements -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  The Best Seller is Also the No. 1 in Mileage. Click here -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  Learn How One City is Running on FOOD SCRAPS. -  One Partnership Endless Possibilities. Click here to know more -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More